Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Gumpelmair

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biochemical Pharmacology|March 9, 2026
Evaluation of small molecule PD-1/PD-L1 inhibitors in a T cell reporter systemJudith Leitner, Helene Schindler, Simon Gumpelmair, et al.
RSC Chemical Biology|March 16, 2026
Bifunctional glycolipids targeting TLR4·MD-2 and short pentraxinsDaniele Zucchetta, Lena Nuschy, Simon Gumpelmair, et al.
Scandinavian Journal of Immunology|January 1, 2020
A simple and efficient workflow for generation of knock-in mutations in Jurkat T cells using CRISPR/Cas9Paweł Borowicz, Hanna Chan, Daniel Medina, et al.
Bioorganic Chemistry|November 6, 2025
HVEM-derived peptides as inhibitors of HVEM/LIGHT complex formationPiotr Ciura, Simon Gumpelmair, Emilia Sikorska, et al.
Plant Cell Reports|March 22, 2025
An engineered PD1-Fc fusion produced in N. benthamiana plants efficiently blocks PD1/PDL1 interactionShiva Izadi, Rafaela Abrantes, Simon Gumpelmair, et al.
Journal of Medicinal Chemistry|November 30, 2025
CD160-Derived Peptide as a Bidirectional Inhibitor Toward Immune Checkpoints BTLA/HVEM and HVEM/LIGHTMagdalena Lipińska, Piotr Ciura, Simon Gumpelmair, et al.
Plant Biotechnology Journal|December 5, 2023
Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR bindingShiva Izadi, Simon Gumpelmair, Pedro Coelho, et al.
Nature Communications|November 28, 2023
Interrogating ligand-receptor interactions using highly sensitive cellular biosensorsMaximilian A Funk, Judith Leitner, Marlene C Gerner, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biochemical Pharmacology|March 9, 2026
Evaluation of small molecule PD-1/PD-L1 inhibitors in a T cell reporter systemJudith Leitner, Helene Schindler, Simon Gumpelmair, et al.
RSC Chemical Biology|March 16, 2026
Bifunctional glycolipids targeting TLR4·MD-2 and short pentraxinsDaniele Zucchetta, Lena Nuschy, Simon Gumpelmair, et al.
Scandinavian Journal of Immunology|January 1, 2020
A simple and efficient workflow for generation of knock-in mutations in Jurkat T cells using CRISPR/Cas9Paweł Borowicz, Hanna Chan, Daniel Medina, et al.
Bioorganic Chemistry|November 6, 2025
HVEM-derived peptides as inhibitors of HVEM/LIGHT complex formationPiotr Ciura, Simon Gumpelmair, Emilia Sikorska, et al.
Plant Cell Reports|March 22, 2025
An engineered PD1-Fc fusion produced in N. benthamiana plants efficiently blocks PD1/PDL1 interactionShiva Izadi, Rafaela Abrantes, Simon Gumpelmair, et al.
Journal of Medicinal Chemistry|November 30, 2025
CD160-Derived Peptide as a Bidirectional Inhibitor Toward Immune Checkpoints BTLA/HVEM and HVEM/LIGHTMagdalena Lipińska, Piotr Ciura, Simon Gumpelmair, et al.
Plant Biotechnology Journal|December 5, 2023
Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR bindingShiva Izadi, Simon Gumpelmair, Pedro Coelho, et al.
Nature Communications|November 28, 2023
Interrogating ligand-receptor interactions using highly sensitive cellular biosensorsMaximilian A Funk, Judith Leitner, Marlene C Gerner, et al.
Pageof 1